Expertise
We offer forward-thinking and detailed counsel across a wide range of practice areas and sectors.
See all expertise
About Us
Wildeboer Dellelce is one of Canada’s premier corporate, securities and business transaction law firms.
Join Us
Take the next step in your career with a welcoming team and open firm culture.
Life Sciences, Healthcare & Pharmaceuticals
For organizations large and small, we provide comprehensive advice on what makes sense for our clients, from growing business and raising capital, to M&A mandates and research partnership agreements.
Key contacts
-
James Brown Partner -
Rory Cattanach Partner -
-
Marcus Hinkley Partner -
Charlie Malone Partner -
Sanjeev Patel Partner -
Michael Rennie Partner -
Peter Volk Partner -
-
-
-
Overview
Our lawyers have extensive experience advising organizations across the life sciences, healthcare and pharmaceutical industries at every stage of development, from emerging growth companies to established multinational enterprises.
We provide practical, business-focused advice tailored to each client’s needs, supporting companies through their entire lifecycle—from formation and early-stage financing through commercialization, strategic partnerships, mergers and acquisitions, and liquidity events. Our multidisciplinary team advises on corporate and securities matters, mergers and acquisitions, regulatory compliance, corporate governance, tax, real estate, commercial agreements and other day-to-day business matters.
We regularly assist clients with a wide range of commercial arrangements, including non-disclosure agreements, master services agreements, supply agreements, licensing agreements and research collaboration agreements.
Our clients include emerging and established domestic and international companies in the pharmaceutical, biotechnology, psychedelic, telehealth, veterinary and dental sectors. We also advise government and quasi-governmental agencies, healthcare service providers, research institutions, financial institutions and investors, including private equity firms pursuing platform and roll-up strategies, as well as investment banks engaged in financing transactions.
Latest News
